---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-024908"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2024-02-16T23:59:59+00:00"
generated_at: "2026-06-06T00:13:54.606630+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nasdaq notifies Jaguar Health of delisting due to low stock price; hearing available

## Summary
- Nasdaq determined to delist JAGX effective Feb 26, 2024, as stock closed at $0.10 or less for 10 consecutive trading days.
- Company may request a hearing by Feb 22, 2024, to stay suspension pending Panel decision.
- Previous bid price deficiency notice was given May 2023; extension until May 6, 2024 was in effect.
- No assurance that the Panel will grant an extension if hearing is requested.

## SEC filing metadata
- accession: 0001104659-24-024908
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2024-02-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000110465924024908/0001104659-24-024908-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000110465924024908/tm246476d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-024908
- JSON: https://secwatch.observer/filing/0001104659-24-024908.json
- Plain text: https://secwatch.observer/filing/0001104659-24-024908.txt

## Key facts
- Listing & Compliance Notices
  Jaguar Health, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iii)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)(iii)
  source text: February 15, 2024, the Company received a letter from the Staff notifying the Company that as of February 14, 2024, the Company's common stock had a closing bid price of $0.10 or less for 10 consecutive trading days. Accordingly, the Company is subject to the provisions contemplated under Nasdaq Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”). As a result, the Staff has issued a letter notifying the Company of its determination to delist the Company’s securities from Nasdaq effective as of the opening of business on February 26, 2024, unless the Company requests an appeal before
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000110465924024908/0001104659-24-024908-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.